AstraZeneca shares fall 5% on disappointing lung cancer drug trial

[Pelican Press 0]

This is the hidden content, please

• Sign In
• or
• Sign Up

AstraZeneca shares fall 5% on disappointing lung ******* ***** trial

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung ******* ***** trial results.

The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday

This is the hidden content, please

• Sign In
• or
• Sign Up

that its experimental ***** did not significantly improve overall survival results for patients.

Share were down 4.9% by 9:43 a.m. London time.

This is a breaking news story. Please check back for updates.

This is the hidden content, please

• Sign In
• or
• Sign Up

#AstraZeneca #shares #fall #disappointing #lung #******* #***** #trial

This is the hidden content, please

• Sign In
• or
• Sign Up

This is the hidden content, please

• Sign In
• or
• Sign Up